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Staphylococcus aureus is an important cause of bloodstream infections. Therefore, the main
purpose of this work was to characterize a collection of 139 S. aureus isolates from blood-
stream infections in two public hospitals in relation to their antimicrobial susceptibility
proﬁle, staphylococcal cassette chromosome mec types, and clonal relationship. Methi-
cillin  resistance and resistance to other 12 agents were accessed by the disk diffusion test.
Minimum inhibitory concentration to mupirocin was also determined. The SCCmec types
were accessed by multiplex PCR, and the clonal relationship was determined by pulsed
ﬁeld  gel electrophoresis method and restriction modiﬁcation system characterization.
Besides, multilocus sequence typing was performed for representative methicillin-resistant
S.  aureus isolates. The military hospital showed a dissemination of the New York/Japan
(USA100/ST5/CC5/SCCmecII)  lineage associated to multidrug resistance, including mupirocin
resistance, and the teaching hospital presented polyclonal and non-multidrug resistant
MRSA isolates. Complete substitution of the Brazilian endemic clone by other lineages was
found  in both hospitals. These ﬁndings can highlight differences in policy control and pre-
vention of infections used in the hospitals and a change in the epidemiological proﬁle of
MRSA in Brazilian hospitals, with the replacement of BEC, a previously well-establishedclone, by other lineages.
© 2016 Sociedade Brasileira de Infectologia. Published by Elsevier Editora Ltda. This is an
open  access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/Please cite this article in press as: Chamon RC, et al. Complete substitu
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Staphylococcus aureus is considered an important cause
of bloodstream infections (BSI), which is associated
with high rates of mortality and morbidity.1 Analysis of
molecular characteristics of S. aureus isolates have indicated
a variety of circulating lineages inside hospitals, according
to the geographic area. In United States, the New York/Japan
clone (USA100/ST5/CC5/SCCmecII) has been replaced by the
community-acquired MRSA (USA300/ST8/CC8/SCCmecIV)
lineage.1 In China, two pandemic hospital-acquired MRSA
(HA-MRSA) clones are disseminated, the Brazilian endemic
clone (BEC/ST239/CC8/SCCmecIII) and the USA100.2 In Brazil,
the BEC lineage remained prevalent inside hospitals,3 but an
increasing presence of the clones USA400 (ST1/CC1/SCCmecIV)
and the Pediatric clone (USA800/ST5/CC5/SCCmecIV) have
been reported in the last decade.3,4 More  recently, SCCmecII
carrying isolates associated to the CC5 were detected
replacing, almost completely the BEC lineage among BSI
isolates at a hospital located in São Paulo city.5
The implementation of a Health Care Associated Preven-
tion and Control Committee (HAIPCC) is mandatory by law in
Brazilian hospitals since 1997.6 These measures apply to the
whole health care system, such as the public and the private
sector. Public hospitals are responsible for the care of about
75% of the Brazilian population, estimated in 192 millions of
habitants (2012 data). However, funding for the Uniﬁed Health
System (Sistema Único de Saúde – SUS) has not been sufﬁcient
to ensure adequate ﬁnancial resources for the public health
system, leading to inappropriate control of dissemination of
endemic resistant microorganisms.6 The aim of the present
study was to characterize S. aureus isolates from BSI at two
public hospitals as their antimicrobial resistance and clonal
dissemination associated with clinical aspects.
We evaluated 139 S. aureus consecutive isolates from BSI
recovered in a 532-bed military hospital (Hospital 1) and in a
490-bed university teaching hospital (Hospital 2), both locatedPlease cite this article in press as: Chamon RC, et al. Complete substitu
Staphylococcus aureus lineages in two public hospitals in Rio de Janeiro, Bra
in Rio de Janeiro city, between January 2008 and June 2009. This
study was approved by the Research Ethics Committee under
No. 159/07. Clinical data from patients with S. aureus BSI were
Table 1 – Distribution of 139 methicillin-susceptible and -resist
clonal complexes from bloodstream infections.
Hospital/methicillin-resistance
(number of isolates)
SCCmec type 
II III IV 
Hospital 1
MRSA (32) 22 (69) 0 10 (31) 
MSSA (43) – – – 
Total (75) 
Hospital 2
MRSA (13) 2 (23) 1* (8) 9 (69) 
MSSA (51) – – – 
Total (64) 
MRSA, methicillin-resistant S. aureus; MSSA, methicillin-susceptible S. aur
mined; N, number.
∗ ST889/CC5. 6;x x x(x x):xxx–xxx
retrospectively abstracted from the hospital records. S. aureus
isolates were identiﬁed by standard methods. BSIs were clas-
siﬁed as hospital-acquired (HA) or community-acquired (CA)
according to the Centers for Disease Control (CDC) criteria.
In order to characterize methicillin resistance, cefoxitin
disk diffusion test was used according to CLSI.7 Isolates
identiﬁed as MRSA were also submitted to antimicrobial sus-
ceptibility test for 12 agents by the disk diffusion method.7
Minimum inhibitory concentration (MIC) to mupirocin was
determined by Etest
®
(AB-Biodisk, Solna, Sweden). The
SCCmec types were assessed by multiplex-PCR for MRSA
isolates.8 Clonal relationship was determined by pulsed-ﬁeld
gel electrophoresis (PFGE).9 Restriction modiﬁcation system
characterization (RM test)10 was used to identify the clonal
complexes (CC) of methicillin susceptible S. aureus (MSSA)
isolates. Besides, multilocus sequence typing (MLST) was per-
formed for representative MRSA isolates.11 The Fisher’s exact
test and chi-square test were used to compare categorical
data. Signiﬁcance level was established at 5% (p < 0.05).
The distribution of the 139 S. aureus isolates and their
SCCmec types and clonal complexes in each hospital is shown
in Table 1. Out of 75 isolates of Hospital 1 (H1), 32 (43%) were
characterized as MRSA, whereas in Hospital 2 (H2) from 64 iso-
lates 13 (20%) were MRSA isolates (p = 0.006). While at H1 the
majority of MRSA isolates carried the SCCmec  type II (69%), at
H2 the SCCmec type IV (69%) was the most prevalent. Overall,
only one isolate from H2 carried the SCCmec  type III and was
assigned as ST889/CC5. In relation to the CC assignment, the
majority of MRSA and MSSA isolates (83%; 62/75) at H1 were
related to CC1 and CC5. However, there was a polyclonal dis-
tribution of S. aureus isolates causing BSI (CCs 1, 5, 8, 30, 45,
221) at H2 regardless of their methicillin resistance.
Characteristics of 45 MRSA isolates from BSI of patients
from the two hospitals evaluated are presented in Table 2.
Overall, 93% (42 isolates), 75% (34), and 35% (16) of the MRSAtion of the Brazilian endemic clone by other methicillin-resistant
zil. Braz J Infect Dis. 2016. http://dx.doi.org/10.1016/j.bjid.2016.09.015
isolates were resistant to ciproﬂoxacin, clindamycin, and
mupirocin, respectively. Among the MRSA isolates from H1,
resistance to three or more  drug classes (multidrug resistance
ant Staphylococcus aureus isolates, SCCmec  types and
N  (%) of isolates
Clonal complexes
1 5 8 30 45 221 ND
9 (28) 23 (72) 0 0 0 0 0
14 (32) 16 (37) 1 (3) 2 (5) 4 (9) 0 6 (14)
23 (31) 39 (52) 1 (1) 2 (3) 4 (5) 0 6 (8)
3 (23) 7 (53) 0 1 (8) 1 (8) 1 (8) 0
17 (33) 6 (12) 7 (14) 7 (14) 4 (8) 0 10 (19)
20 (31) 13 (20) 7(11) 8 (12.5) 5 (8) 1 (2) 10 (15.5)
eus; SCCmec,  Staphylococcal cassette chromosome mec;  ND, not deter-
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Table 2 – General characteristics of 45 methicillin-resistant Staphylococcus aureus isolates from bloodstream infections.
Hospital/genotype
(no of isolates)
Isolate
number
Isolation date
(mm/dd/yy)
Unit or
ﬂoor
Acquisition
mode
SCCmec
type
PFGE
subtype
Clonality ST/CC Antimicrobial
resistance
proﬁle
Hospital 1 (32)
A (22) 1223a 01/10/2008 11 HA II A1 USA100 5/5 cip cli ery mup tec
1224a 01/12/2008 ICU HA II A1 USA100 5/5 cip cli ery mup
1255a 09/02/2008 ICU HA II A1 USA100 5/5 cip cli ery mup
1258a 09/16/2008 ICU HA II A1 USA100 5/5 cip cli ery mup
1265a 09/23/2008 9 HA II A1 USA100 5/5 cip cli ery mup
1266a 09/24/2008 9 HA II A1 USA100 5/5 cip cli ery mup
1276a 02/12/2008 9 HA II A1 USA100 5/5 cip cli ery mup
1288a 03/12/2009 ICU HA II A1 USA100 5/5 cip cli ery mup
1289a 03/13/2009 11 HA II A1 USA100 5/5 cip cli ery mup
1309a 03/14/2009 ND HA II A1 USA100 5/5 cip cli ery mup clo rif
1290a 03/19/2009 11 HA II A1 USA100 5/5 cip cli clo ery
1291a 03/31/2009 9 HA II A1 USA100 5/5 cip cli ery mup
1305a 06/04/2009 11 HA II A1 USA100 5/5 cip cli ery mup clo rif
1308a 06/15/2009 10 HA II A1 USA100 5/5 cip cli ery mup clo rif
1260a 09/17/2008 10 HA II A2 USA100 5/5 cip cli ery
1263a 09/22/2008 11 HA II A2 USA100 5/5 cip cli ery
1275a 12/02/2008 ICU HA II A2 USA100 5/5 cip cli ery
1238a 05/26/2008 8 HA II A3 USA100 5/5 cip cli ery mup
1240a 05/27/2008 Em HA II A3 USA100 5/5 cip cli ery mup
1284a 02/02/2009 Em HA II A4 USA100 5/5 cip cli ery
1285a 02/16/2009 11 HA II A4 USA100 5/5 cip cli ery
1301a 05/27/2009 IU HA II A5 USA100 5/5 cip cli clo ery
B (9) 1229a 02/09/2008 11 HA IV B1 USA400 1/1 cip cli ery
1237a 05/20/2008 11 HA IV B1 USA400 1/1 cip cli ery
1307a 06/12/2009 ICU HA IV B1 USA400 1/1 cip clo
1231a 02/13/2008 11 HA IV B2 USA400 1/1 cip
1282a 01/22/2009 ICU HA IV B2 USA400 1/1 cip clo
1268a 09/26/2008 10 HA IV B3 USA400 1/1 cip cli ery gen
1283a 01/22/2009 ICU HA IV B3 USA400 1/1 cip clo
1295a 05/25/2009 9 HA IV B4 USA400 1/1 –
1302a 05/21/2009 ICU HA IV B5 USA400 1/1 cip clo
F (1) 1306a 06/04/2009 10 HA II F ND 105/5 cip cli clo ery
Hospital 2 (13)
A (1) 1087a 01/20/2008 11 HA II A1 USA100 5/5 cip cli ery mup
B (3) 1094a 01/16/2008 9 CA IV B1 USA400 1/1 cip cli ery
1187a 06/12/2008 8 HA IV B1 USA400 1/1 cip cli clo ery
1100a 01/27/2008 Em CA IV B2 USA400 1/1 cip cli ery
C (5) 1214a 06/26/2009 7 HA IV C1 USA800 5/5 –
1318a 08/16/2008 Em HA IV C2 USA800 5/5 cip
1324a 08/08/2008 Em HA IV C3 USA800 5/5 cip
1328a 12/23/2008 Em HA IV C4 USA800 5/5 cip cli ery
1326a 12/25/2008 9 HA IV C4 USA800 5/5 –
D (1) 1314a 11/08/2008 7 HA IV D ND 484/30 cip cli ery
E (1) 1092a 02/22/2008 9 HA III E ND 889/5 cip clo ery gen sut tec
G (1) 1212a 06/02/2009 ICU HA II G ND 3050/45 cip cli ery
H (1) 1219a 06/06/2009 8 HA II H ND 221/221 cip cli ery
ICU, intensive care unit; Em, emergency; ND, not determined; HA, hospital acquired; CA, community acquired; SCCmec,  Staphylococcal cas-
quen
l; rif, 
–
i
M
t
(
c
m
asette chromosome mec;  PFGE, pulsed ﬁeld gel electrophoresis; ST, se
erythromycin; mup, mupirocin; tec, teicoplanin; clo, chloramphenico
 MDR) was veriﬁed in 59.3% (19/32), while among the MRSA
solates from H2, MDR  was found in only 23% (3/13) (p = 0.05).
oreover, 97% of the MRSA isolates from H1 were related
o only two disseminated lineages, USA100/ST5/CC5/SCCmecII
69%) and USA400/ST1/CC1/SCCmecIV (28%), all of themPlease cite this article in press as: Chamon RC, et al. Complete substitu
Staphylococcus aureus lineages in two public hospitals in Rio de Janeiro, Bra
ausing hospital-acquired BSI. Furthermore, 94% (15/16) of
upirocin-resistant isolates were found at H1 and it was
ssociated to the USA100 lineage. Two USA100 isolatesce type; CC, clonal complex; cip, ciproﬂoxacin; cli, clindamycin; ery,
rifampin; gen, gentamicin; sut, sulfamethoxazole/trimethoprim.
(1238a and 1240a) showed high levels of mupirocin resis-
tance (MIC > 1024 g/mL) (data not shown). In this hospital,
the prevalent USA100/ST5/SCCmecII lineage was found widely
disseminated. At H2, 62% of MRSA isolates carried the SCCmec
IV and were related to USA800 (38%) or USA400 (23%) lineages.tion of the Brazilian endemic clone by other methicillin-resistant
zil. Braz J Infect Dis. 2016. http://dx.doi.org/10.1016/j.bjid.2016.09.015
Besides, the polyclonal presence of sporadic lineages (STs 484,
889, 3050, and 221) was identiﬁed in this hospital, the ST3050
being described for the ﬁrst time in this study.
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In our study, 139 S. aureus isolates from BSI obtained at
two different public hospitals in Rio de Janeiro city were
characterized regarding their antimicrobial resistance and
clonal proﬁle. We  veriﬁed that almost 70% of the BSI isolates
from the military public hospital (H1) carried the SCCmecII and
were related to the USA100 lineage. All but one isolate were
assigned as USA400 lineage. This lineage appears to have sur-
vival and growth advantage since it has remained for years
as a major hospital-associated lineage in USA and Japan1,12
showing the good adaptability of such clone, even in different
geographic areas.
At H2, a reference teaching public hospital, a polyclonal
proﬁle was observed for the MRSA isolates. Interestingly,
we previously found a similar higher clonal diversity among
MRSA isolates at a private hospital.3 These ﬁndings may be
a reﬂection of the occurrence of fewer outbreaks due to ade-
quate infection control measures at this particular institution,
as found in this teaching public hospital. Padoveze et al.6 con-
ducted a cross-sectional study evaluating a collection of 153
hospitals from ﬁve different Brazilian regions. The authors
showed that a minimal structure is necessary for an effective
prevention of hospital infections, specially the presence of an
active HAIPCC, as well as sterilization services, hand hygiene
resources, and a microbiology laboratory.
Caboclo et al.3 compared S. aureus isolates from two health
institutions in Rio de Janeiro between 2004 and 2007. One of
these institutions was the same military hospital (H1) of the
current study. The authors showed a dissemination of the
USA100, USA400, USA800 and BEC lineages at this military
institution. Moreover, around 60% of the isolates were from
the BEC lineage, showing that at the time this lineage was still
highly present. Simultaneously, similar results were found in a
study conducted at a private tertiary care hospital in São Paulo
where 40% (13/33) of MRSA isolates belonged to BEC and 21%
were related to the USA100 lineage.13 At H2, Cavalcante et al.14
showed that the BEC lineage was responsible for around 30% of
all MRSA isolates, between 2005 and 2006. In the present study,
carried out between 2008 and 2009, complete absence of the
BEC lineage was veriﬁed in both public institutions evaluated,
showing that certain global MRSA lineages are replacing BEC.
Caiaffa-Filho et al.5 recently evaluated a collection of 50 con-
secutive MRSA BSI isolates in a São Paulo tertiary care teaching
hospital, between October and December 2010, and found that
a single PFGE clone related to the USA100 lineage was dissem-
inated, almost replacing the BEC in that institution during the
study period. This ﬁnding highlights a possible change in the
epidemiological proﬁle of MRSA in Brazilian hospitals.
MRSA isolates were more  frequently found at H1 than in
the teaching hospital (H2) being associated to a MDR  proﬁle
and mupirocin resistance. In Brazil, despite the legislation
mandating the implementation of HAIPCC in the health sys-
tem, the lack of qualiﬁed professionals, the growing health
costs, and limited availability of ﬁnancial resources are of
great impact in the infection control.6 Therefore, the dif-
ferences regarding resistance rates observed between MRSA
isolates from the H1 and H2, as well as the prevalence ofPlease cite this article in press as: Chamon RC, et al. Complete substitu
Staphylococcus aureus lineages in two public hospitals in Rio de Janeiro, Bra
speciﬁc SCCmec types, may be a reﬂection of the policy for
control and prevention of infections and use of antimicro-
bials in the hospitals evaluated. Interestingly, the prevalent
USA100 clone presenting MDR  proﬁle isolated from H1 had 6;x x x(x x):xxx–xxx
already been described as a MRSA-daptomycin-resistant iso-
late with vancomycin MIC of 4 g/mL, also causing BSI,15
conﬁrming the ability of this lineage to acquire resistance
determinants. Moreover, this lineage was also associated with
mupirocin resistance, a drug used for decolonizing MRSA
nasal carriage.2 Although only two isolates have showed high
levels of mupirocin resistance (MIC > 1024 g/mL), both high-
and low-level resistance have been associated with S. aureus
decolonization failure.2 As showed in a study conducted
in China,2 USA100/ST5 isolates associated with mupirocin
resistance lead to possible outbreaks. The dissemination of
mupirocin-resistant MRSA isolates among H1 patients in our
study also highlights the importance of the judicious use of
mupirocin among the hospitalized patients.
MRSA, as well as MSSA isolates, have been reported as
important causes of nosocomial infections, such as BSI.1 The
present study showed that S. aureus isolates from the CCs
1 and 5, regardless their methicillin-resistance status, had
similar clonality at both hospitals. According to Diep and
Otto,16 the emergence of the MRSA lineages around the world
may be related to the successful conversion of certain MSSA
isolates into MRSA isolates by the acquisition of SCCmec. The
presence of MSSA and MRSA isolates presenting the same
CCs and/or STs have already been observed in Rio de Janeiro
hospitals,4 indicating the ability of certain lineages to acquire
the mec cassette thus providing an advantage to their spread-
ing in health institutions.
In conclusion, although both institutions evaluated in
the present study are public hospitals, the military hospi-
tal showed dissemination of the USA100/ST5/CC5/SCCmecII
lineage associated to multidrug resistance, including to
mupirocin. On the other hand, the teaching hospital presented
polyclonal and non-multidrug resistant MRSA isolates. These
differences may reﬂect the policy of control and prevention
of infections and/or use of antimicrobials employed in each
hospital evaluated. Moreover, complete substitution of the
BEC/ST239/SCCmecIII by other lineages was found in both hos-
pitals, highlighting a change in the epidemiological proﬁle of
MRSA in Brazilian hospitals.
Ethics  statement
The present study was approved by the Research Ethics Com-
mittee under No. 159/07.
Conﬂicts  of  interest
The authors declare no conﬂicts of interest.
Acknowledgments
This study was supported by grants from: Fundac¸ão Carlos
Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeirotion of the Brazilian endemic clone by other methicillin-resistant
zil. Braz J Infect Dis. 2016. http://dx.doi.org/10.1016/j.bjid.2016.09.015
(FAPERJ), Conselho Nacional de Desenvolvimento Cientíﬁco e
Tecnológico (CNPq), Coordenac¸ão de Aperfeic¸oamento Pessoal
de Nível Superior (CAPES), Fundac¸ão Universitária José Bonifá-
cio (FUJB) and Programa de Núcleos de Excelência (PRONEX).
ARTICLE IN PRESSBJID-662; No. of Pages 5
 2 0 1 6
r
U
v
M
r
1
1
1
1
1
1
http://dx.doi.org/10.1186/1756-0500-7-759.b  r a z j i n f e c t d i s .
We  acknowledge the contribution of PhD Rosana Bar-
eto Rocha Ferreira (Instituto de Microbiologia Paulo de Góes,
niversidade Federal do Rio de Janeiro, Rio de Janeiro) for pro-
iding language help and of the student Juliana Curityba de
ello Campos for the help in some experiments.
 e  f  e  r  e  n  c  e  s
1. Rhee Y, Aroutcheva A, Hota B, et al. Evolving epidemiology of
Staphylococcus aureus bacteremia. Infect Control Hosp
Epidemiol. 2015;36:1417–22,
http://dx.doi.org/10.1017/ice.2015.213.
2.  Liu Q, Han L, Li B, et al. Virulence characteristic and MLST-agr
genetic background of high-level mupirocin-resistant, MRSA
isolates from Shanghai and Wenzhou, China. PLoS ONE.
2012;7:e37005, http://dx.doi.org/10.1371/journal.pone.0037005.
3. Caboclo RM, Cavalcante FS, Iorio NL, et al.
Methicillin-resistant Staphylococcus aureus in Rio de Janeiro
hospitals: dissemination of the USA400/ST1 and USA800/ST5
SCCmec type IV and USA100/ST5 SCCmec type II lineages in a
public institution and polyclonal presence in a private one.
Am J Infect Control. 2013;41:e21–6,
http://dx.doi.org/10.1016/j.ajic.2012.08.008.
4.  Schuenck RP, Cavalcante FS, Emery E, et al. Staphylococcus
aureus isolates belonging to different multilocus sequence
types present speciﬁc virulence gene proﬁles. FEMS Immunol
Med Microbiol. 2012;65:501–4,
http://dx.doi.org/10.1111/j.1574-695X.2012.00958.x.
5.  Caiaffa-Filho HH, Trindade PA, da Cunha GP, et al.
Methicillin-resistant Staphylococcus aureus carrying SCCmec
type II was more frequent than the Brazilian endemic clone
as  a cause of nosocomial bacteremia. Diagn Microbiol Infect
Dis. 2013;76:518–20,
http://dx.doi.org/10.1016/j.diagmicrobio.2013.04.024.Please cite this article in press as: Chamon RC, et al. Complete substitu
Staphylococcus aureus lineages in two public hospitals in Rio de Janeiro, Bra
6.  Padoveze MC, Fortaleza CM, Kiffer C, et al. Structure for
prevention of health care-associated infections in Brazilian
hospitals: a countrywide study. Am J Infect Control.
2016;44:74–9, http://dx.doi.org/10.1016/j.ajic.2015.08.004.
1;x  x x(x x):xxx–xxx 5
7. Clinical and Laboratory Standards Institute – CLSI.
Performance standards for antimicrobial disk susceptibility
testing. Approved standards: M100-S16. Wayne, Pennsylvania,
USA; 2015.
8. Milheiric¸o C, Oliveira DC, De Lencastre H. Update to the
multiplex PCR strategy for assignment for mec element in
Staphylococcus aureus.  Antimicrob Agents Chemother.
2007;51:3374–7.
9. Vivoni AM, Diep BA, De-Gouveia-Magalhães AC, et al. Clonal
composition of Staphylococccus aureus isolates at a Brazilian
university hospital: identiﬁcation of international circulating
lineages. J Clin Microbiol. 2006;44:1686–91.
0. Cockﬁeld JD, Pathak S, Edgeworth JD, et al. Rapid
determination of hospital-acquired methicillin-resistant
Staphylococcus aureus lineages. J Med  Microbiol. 2007;56:614–9.
1. Enright MC, Day NPJ, Davies CE, et al. Multilocus sequence
typing for characterization of methicillin-resistant and
methicillin-susceptible clones of Staphylococcus aureus.  J Clin
Microbiol. 2000;38:1008–15.
2. Nakaminami H, Noguchi N, Ito A, et al. Characterization of
methicillin-resistant Staphylococcus aureus isolated from
tertiary care hospitals in Tokyo, Japan. J Infect Chemother.
2014;20:512–5, http://dx.doi.org/10.1016/j.jiac.2014.03.006.
3.  Martino MDV, Correa L, Pignatari ACC, et al. Isolates of
methicillin-resistant Staphylococcus aureus (MRSA) not
belonging to the Brazilian epidemic clone. Saf Health.
2015;1:9, http://dx.doi.org/10.1186/s40886-015-0001-6.
4. Cavalcante FS, Schuenck RP, Ferreira DC, et al.
Methicillin-resistant Staphylococcus aureus:  spread of speciﬁc
lineages among patients in different wards at a Brazilian
teaching hospital. J Hosp Infect. 2014;86:151–4,
http://dx.doi.org/10.1016/j.jhin.2013.12.004.
5. Cavalcante FS, Ferreira DC, Chamon RC, et al. Daptomycin
and methicillin-resistant Staphylococcus aureus isolated from a
catheter-related bloodstream infection: a case report. BMC
Res Notes. 2014;25:759,tion of the Brazilian endemic clone by other methicillin-resistant
zil. Braz J Infect Dis. 2016. http://dx.doi.org/10.1016/j.bjid.2016.09.015
6. Diep BA, Otto M. The role of virulence determinants in
community-associated MRSA pathogenesis. Trends Microbiol.
2008;16:361–9, http://dx.doi.org/10.1016/j.tim.2008.05.002.
